Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
47
Number of overlapping holdings
55.3%
% of WDNA's 90 holdings also in IBB
20.9%
% of IBB's 263 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.0% | 2.2% | 2.2% |
|
UNITED THERAPEUTICS CORP | 1.8% | 1.6% | 1.6% |
|
ALNYLAM PHARMACEUTICALS INC | 1.5% | 3.1% | 1.5% |
|
GILEAD SCIENCES INC | 1.4% | 8.3% | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 1.4% | 7.5% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to IBB
|
TWIST BIOSCIENCE CORP. | 3.6% |
 |
NOVOZYMES A/S-B SHARES | 3.5% |
|
VERICEL CORPORATION | 2.5% |
|
ELI LILLY & CO | 2.3% |
|
VERACYTE INC | 2.1% |
|
BLUEPRINT MEDICINES CORP. | 1.9% |
|
GERON CORP | 1.9% |
|
NATERA INC | 1.8% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
|
BRIDGEBIO PHARMA, INC. | 1.6% |
WDNA Underweight Relative to IBB
|
GILEAD SCIENCES INC | -6.9% |
|
AMGEN INC | -6.7% |
|
REGENERON PHARMACEUTICALS | -6.3% |
|
VERTEX PHARMACEUTICALS INC | -6.0% |
|
IQVIA HOLDINGS INC | -3.7% |
 |
METTLER-TOLEDO INTERNATIONAL | -2.5% |
|
WATERS CORP | -2.3% |
 |
ARGENX SE ADR | -2.2% |
|
ALNYLAM PHARMACEUTICALS INC | -1.6% |
|
BIOGEN IDEC INC | -1.5% |